CRIS
CurisCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
CRIS vs peer average
72/100
CRIS vs. peer average (C vs. D)
Grade spread
B 1 · D 2 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
LABT is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $678K
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CRIS
Curis
LABT
Lakewood-Amedex Biotherapeutics
Grade
C
D
Momentum
14
0
Value
58
57
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs LABT
CRIS / LABT
Grade Position
Above peers
CRIS vs. peer average (C vs. D)
72/100
Momentum
14
CRISValue
58
CRISSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CRIS
LABT is the first peer returned for this comparison set.